Freezing of Gait Treatment Market By Treatment Type (Oral Dopaminergic Medication, Wearable and Walking Aid Devices, Deep Brain Stimulation), By End User Segment (Hospitals, Clinics, Research and Academic Institutes) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027
"Freezing of gait treatment market to exhibit productive growth during the forecast period"
The global freezing of gait treatment market is growing effectually, expected to grow at a CAGR of 7.2%. Globally, increasing prevalence of Parkinson's disease has significantly increased the revenue of oral dopaminergic medications. FDA approval for new drugs, and promising pipeline products in the equipment and devices segment in the Parkinson's disease industry are driving the overall growth freezing of gait treatment market globally.
"Oral dopaminergic medication segment is expected to register higher growth by the end of 2027"
Levodopa (Inbrija™, by Acorda Therapeutics), along with carbidopa, remains the optimum standard of symptomatic treatment for (FoG) Parkinson disease orally. In Dec 2018, the U.S. FDA approved Inbrija™ for the alternating treatment of “OFF” incidents in people with Parkinson’s disease who are already treated with levodopa/carbidopa. It is a novel approach for the treatment of OFF periods in PD. Advanced pipeline products in the wearable and walking aid segment will show promising growth in near future. For e.g. In the CES 2018 conference in Las Vegas, a Chinese company named GYENNO showcased its gait aid equipment package, mainly helps to escape gait freeze in Parkinson’s patients. Additionally, Kyungpook National University showcased android based gait-aid system by using smart glasses with wearable sensors.
"Increasing admissions for freezing of gait in the hospital segment to witness a significant CAGR"
Increasing chronic Parkinson’s disease (PD) along with significant admissions in the hospitals internationally are notable factors expected for the growth of the market. According to FDA and other research studies, symptomatic and neuroprotective therapies are opted for PD in hospitals. Deep brain stimulation procedures along with helpful brain exercises are also adopted in the end user segment, showed promising results in recent time. Moreover, increasing elderly population along with increasing admissions is escalating the growth in the end-user segment. Moreover, lunch of new medications and equipment in the U.S. market and internationally along with increased funding for PD patient care for the administrations of freezing of gait treatment on a global scale will drive the growth during the forecast period.
"Increasing population, new FDA approval and the presence of top players holds the U.S. in dominant position"
In 2018, the U.S contributed maximum revenue share in the freezing of gait treatment market due to the rising prevalence of PD. Key prime factors include rising awareness about new medications and therapies, FDA approvals for new drugs, and rising PD care services along with enhanced reimbursement structure will drive the demand in near future. Emerging nations always suffer the burden of chronic diseases. Nevertheless, there is no significant treatment targeted towards freezing of gait in PD, but strong pipeline drugs and products along with the approval for levodopa will further enhance the growth on a global scale.
"Increased research and development with strong product pipelines in the developed regions"
Major players in the freezing of gait treatment market are Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, National University of Ireland, Galway (NUI Galway), Kyungpook National University, Republic of Korea, MedEXO Robotics, TABLE Teva Pharmaceuticals and others. Major organizations and research centers are developing progressive technologies with new technology expansion in the wearable and walking aids systems, electronic brain implants and other stimulators for freezing of gait treatment on a global scale.
Historical & Forecast Period
This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.
Report Scope by Segments
Market Segmentation
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2017-2027 |
| Base Year | 2018 |
| Forecast Period | 2019-2027 |
| Historical Year | 2017 |
| Unit | USD Million |
| Segmentation |
Treatment Type (2017–2027; US$ Mn) |
|
End-User Segment (2017–2027; US$ Mn) |
|
|
Geography Segment (2017–2027; US$ Mn) |
The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall freezing of gait treatment market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Key questions answered in this report
- What are the current market trends and dynamics in the freezing of gait treatment market and valuable opportunities for emerging players?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which treatment type segment holds a larger market share and why?
- Are low and middle-income economies investing in the freezing of gait treatment market?
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global FGT Market Portraiture
2.2. Global FGT Market, By Treatment Type, 2018 (US$ Mn)
2.3. Global FGT Market, By End User, 2018 (US$ Mn)
2.4. Global FGT Market, by Geography, 2018 vs. 2027 (Value %)
Chapter 3. Global Freezing of Gait Treatment (FGT) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. FGT Market Technologies: Future Trends
3.3. Current Scenario: New Product Launches, High Prevalence For Parkinson’s Disease
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2018
Chapter 4. Global Freezing of Gait Treatment (FGT) Market, by Treatment Type, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Oral Dopaminergic Medication (Inbrija - levodopa inhalation powder)
4.3. Wearable and Walking Aid Devices
4.4. Deep Brain Stimulation
4.5. Others (Brain Implants)
Chapter 5. Global Freezing of Gait Treatment (FGT) Market, By End User, 2017 – 2027 (US$)
5.1. Overview
5.2. Hospitals
5.3. Clinics
5.4. Research and Academic Institutes
Chapter 6. Global Freezing of Gait Treatment (FGT) Market, by Geography, 2017 – 2027 (US$ Mn)
6.1. Overview
6.2. North America FGT Market Analysis, 2017 – 2027
6.2.1. North America FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.2.2. North America FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.2.3. North America FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe FGT Market Analysis, 2017 – 2027
6.3.1. Europe FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.3.2. Europe FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific FGT Market Analysis, 2017 – 2027
6.4.1. Asia Pacific FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America FGT Market Analysis, 2017 – 2027
6.5.1. Latin America FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.5.2. Latin America FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) FGT Market Analysis, 2017 – 2027
6.6.1. MEA FGT Market, by Treatment Type, 2017 – 2027 (US$ Mn)
6.6.2. MEA FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA FGT Market, by Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Acorda Therapeutics
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. The Michael J. Fox Foundation
7.3. GYENNO
7.4. National University of Ireland, Galway (NUI Galway)
7.5. Kyungpook National University, Republic of Korea
7.6. MedEXO Robotics
* Here we are using FGT as a short form of Freezing of Gait Treatment
TABLE 1 Market Snapshot: Global Freezing of Gait Treatment (FGT) Market
TABLE 2 Global FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 3 Global FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 4 Global FGT Market, by Geography, 2017–2027 (US$ Mn)
TABLE 5 North America FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 6 North America FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 7 North America FGT Market, by Country, 2017–2027 (US$ Mn)
TABLE 8 Europe FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 9 Europe FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 10 Europe FGT Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 11 Latin America FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 12 Latin America FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 13 Latin America FGT Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 14 Asia Pacific FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 15 Asia Pacific FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 16 Asia Pacific FGT Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 17 Middle East & Africa FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 18 Middle East & Africa FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 19 Middle East & Africa FGT Market, by Region, 2017–2027 (US$ Mn)
TABLE 20 Acorda Therapeutics.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 The Michael J. Fox Foundation.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 GYENNO..: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 National University of Ireland, Galway (NUI Galway): Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Kyungpook National University, Republic of Kore: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 MedEXO Robotics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Teva Pharmaceuticals: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
FIG. 1 Global Freezing of Gait Treatment (FGT) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global FGT Market Segmentation
FIG. 4 Global FGT Market, by Treatment Type, 2017 (US$ Mn)
FIG. 5 Global FGT Market, by End User, 2017 (US$ Mn)
FIG. 6 Global FGT Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key FGT Market Manufacturers, 2017
FIG. 9 Global FGT Market for Oral Dopaminergic Medication, 2017–2027 (US$ Mn)
FIG. 10 Global FGT Market for Wearable and Walking Aid Devices, 2017–2027 (US$ Mn)
FIG. 11 Global FGT Market for Deep Brain Stimulation, 2017–2027 (US$ Mn)
FIG. 12 Global FGT Market for Others (Brain Implants), 2017–2027 (US$ Mn)
FIG. 13 Global Hospitals Market (End User), 2017–2027 (US$ Mn)
FIG. 14 Global Clinics Market (End User), 2017–2027 (US$ Mn
FIG. 15 Global Research and Academic Institutes Market (End User), 2017–2027 (US$ Mn
FIG. 16 U.S. FGT Market, 2017–2027 (US$ Mn)
FIG. 17 Canada FGT Market, 2017–2027 (US$ Mn)
FIG. 18 U.K. FGT Market, 2017–2027 (US$ Mn)
FIG. 19 Germany FGT Market, 2017–2027 (US$ Mn)
FIG. 20 Rest of Europe FGT Market, 2017–2027 (US$ Mn)
FIG. 21 Japan FGT Market, 2017–2027 (US$ Mn)
FIG. 22 China FGT Market, 2017–2027 (US$ Mn)
FIG. 23 Rest of Asia Pacific FGT Market, 2017–2027 (US$ Mn)
FIG. 24 Brazil FGT Market, 2017–2027 (US$ Mn)
FIG. 25 Mexico FGT Market, 2017–2027 (US$ Mn)
FIG. 26 Rest of Latin America FGT Market, 2017–2027 (US$ Mn)
FIG. 27 GCC FGT Market, 2017–2027 (US$ Mn)
FIG. 28 Rest of Middle East & Africa FGT Market, 2017–2027 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)